| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A factor IX variant that functions independently of factor VIII mitigates the hemophilia A phenotype in patient plasma
|
Strijbis, Viola J.F.
|
|
|
21 |
6 |
p. 1466-1477
|
artikel
|
| 2 |
An anticoagulant/procoagulant self-converting and bleeding site–targeting systemic nanotherapy for rapidly controlling noncompressible bleeding without risk of thrombosis
|
Yuan, Yuchuan
|
|
|
21 |
6 |
p. 1478-1492
|
artikel
|
| 3 |
Anti-CD38 antibody for refractory acquired hemophilia A
|
Liu, Wei
|
|
|
21 |
6 |
p. 1515-1518
|
artikel
|
| 4 |
Antidrug antibodies against the polyethylene glycol moiety inhibit the procoagulant activity of therapeutic polyethylene glycolated factor VIII
|
Pezeshkpoor, Behnaz
|
|
|
21 |
6 |
p. 1503-1514
|
artikel
|
| 5 |
A site on factor XII required for productive interactions with polyphosphate
|
Shamanaev, Aleksandr
|
|
|
21 |
6 |
p. 1567-1579
|
artikel
|
| 6 |
A step forward toward understanding the complex dynamics of coagulation in patients with cirrhosis
|
Zanetto, Alberto
|
|
|
21 |
6 |
p. 1426-1428
|
artikel
|
| 7 |
Autoantibodies enhance ADAMTS-13 clearance in patients with immune thrombotic thrombocytopenic purpura
|
Underwood, Mary I.
|
|
|
21 |
6 |
p. 1544-1552
|
artikel
|
| 8 |
Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity
|
Falanga, Anna
|
|
|
21 |
6 |
p. 1397-1408
|
artikel
|
| 9 |
Chorography of blood proteins
|
Weisel, John W.
|
|
|
21 |
6 |
p. 1423-1425
|
artikel
|
| 10 |
Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysis
|
Candeloro, Matteo
|
|
|
21 |
6 |
p. 1592-1600
|
artikel
|
| 11 |
“Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis on sepsis-induced coagulopathy in the management of sepsis”: Comment from Wada et al
|
Wada, Hideo
|
|
|
21 |
6 |
p. 1677-1678
|
artikel
|
| 12 |
“Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis on sepsis-induced coagulopathy in the management of sepsis”: reply
|
Iba, Toshiaki
|
|
|
21 |
6 |
p. 1679-1680
|
artikel
|
| 13 |
Corrigendum to ‘Race, ethnicity, F8 variants and inhibitor risk: Analysis of the “My Life Our Future” Hemophilia A database’ [Journal of Thrombosis and Haemostasis Volume 21, Issue 4, April 2023, Pages 800-813]
|
Ahmed, Anwar E.
|
|
|
21 |
6 |
p. 1684-1685
|
artikel
|
| 14 |
Decision-analysis modeling of effectiveness and cost-effectiveness of pharmacologic thromboprophylaxis for surgical inpatients using variable risk assessment models or other strategies
|
Davis, Sarah
|
|
|
21 |
6 |
p. 1580-1591
|
artikel
|
| 15 |
Definitions of fatal bleeding in clinical studies evaluating anticoagulant treatment for venous thromboembolism: A scoping review
|
Schenker, Carla
|
|
|
21 |
6 |
p. 1553-1566
|
artikel
|
| 16 |
Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2
|
Lombardi, Ludovica
|
|
|
21 |
6 |
p. 1636-1649
|
artikel
|
| 17 |
Generation and characterization of a plasminogen-binding group A streptococcal M-protein/streptokinase-sensitive mouse line
|
Ayinuola, Yetunde A.
|
|
|
21 |
6 |
p. 1630-1635
|
artikel
|
| 18 |
Immune dysregulation, autoimmunity, and granule defects in gray platelet syndrome
|
Collins, Janine H.
|
|
|
21 |
6 |
p. 1409-1419
|
artikel
|
| 19 |
Intraindividual variability over time of thrombin generation in patients with cirrhosis
|
Sinegre, Thomas
|
|
|
21 |
6 |
p. 1441-1452
|
artikel
|
| 20 |
In vitro effects of combining Mim8 with factor VIII, FVIIa, and activated prothrombin complex concentrates in thrombin generation assays
|
Lund, Jacob
|
|
|
21 |
6 |
p. 1493-1502
|
artikel
|
| 21 |
Issue Information
|
|
|
|
21 |
6 |
p. e1-e5
|
artikel
|
| 22 |
ISTH News and Updates: Join the ISTH Today
|
|
|
|
21 |
6 |
p. 1686-1687
|
artikel
|
| 23 |
Major acute cardiovascular events after venous thromboembolism: a meta-analysis of randomized trials
|
Becattini, Cecilia
|
|
|
21 |
6 |
p. 1674-1676
|
artikel
|
| 24 |
2023 Montréal Congress welcome editorial
|
Kahn, Susan R.
|
|
|
21 |
6 |
p. 1395-1396
|
artikel
|
| 25 |
Multidisciplinary care of the pregnant patient with or at risk for venous thromboembolism: a recommended toolkit from the Foundation for Women and Girls with Blood Disorders Thrombosis Subcommittee
|
Samuelson Bannow, Bethany
|
|
|
21 |
6 |
p. 1432-1440
|
artikel
|
| 26 |
Preclinical studies of a factor X activator and a phase 1 trial for hemophilia patients with inhibitors
|
Liu, Wei
|
|
|
21 |
6 |
p. 1453-1465
|
artikel
|
| 27 |
Prediction of recurrent venous thromboembolism: The writing is on the wall
|
Lian, Tian-Yu
|
|
|
21 |
6 |
p. 1420-1422
|
artikel
|
| 28 |
Predictive value for increased activated factor XI activity in acute venous thromboembolism
|
Nagy, Magdolna
|
|
|
21 |
6 |
p. 1610-1622
|
artikel
|
| 29 |
Real-world use of apixaban for the treatment and prevention of thrombosis in children with cardiac disease
|
VanderPluym, Christina
|
|
|
21 |
6 |
p. 1601-1609
|
artikel
|
| 30 |
Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: a systematic review and meta-analysis of individual participant data
|
Robin, Philippe
|
|
|
21 |
6 |
p. 1519-1528.e2
|
artikel
|
| 31 |
“Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis”: Comment
|
Norris, Lucy A.
|
|
|
21 |
6 |
p. 1681-1683
|
artikel
|
| 32 |
Russell’s viper venom: from diagnostic to bypassing agent for hemophilia?
|
Veizaj, Dejvid
|
|
|
21 |
6 |
p. 1429-1431
|
artikel
|
| 33 |
Stroke-induced hexokinase 2 in circulating monocytes exacerbates vascular inflammation and atheroprogression
|
Sun, Yang
|
|
|
21 |
6 |
p. 1650-1665
|
artikel
|
| 34 |
Systematic mapping of the conformational landscape and dynamism of soluble fibrinogen
|
Pinelo, Jose E.E.
|
|
|
21 |
6 |
p. 1529-1543
|
artikel
|
| 35 |
Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis
|
Whitworth, Hilary
|
|
|
21 |
6 |
p. 1666-1673
|
artikel
|
| 36 |
von Willebrand factor antigen: a biomarker for severe pregnancy complications in women with hereditary thrombotic thrombocytopenic purpura?
|
Davidesko, Sharon
|
|
|
21 |
6 |
p. 1623-1629
|
artikel
|
Tijdschrift beschrijving